Genetic Polymorphism in Paraoxonase 1 (PON1): Population Distribution of PON1 Activity

作者: Gary Ginsberg , Patricia Neafsey , Dale Hattis , Kathryn Z. Guyton , Douglas O. Johns

DOI: 10.1080/10937400903158409

关键词:

摘要: Paraoxonase-1 (PON1) is a serum esterase that hydrolyzes the activated oxon form of several organophosphates. The central role PON1 in detoxification organophosphate (OP) pesticides was demonstrated knockout mouse studies, suggesting human variability needs to be considered health risk assessments involving exposure these pesticides. current analysis focused on two genetic loci which polymorphisms affect activity. Detailed kinetic studies and population found *192Q (wild type) allele more active toward some substrates (such as sarin, soman, diazoxon) less others paraoxon or chlorpyrifos) relative variant *192R allele. Another affects activity *55M; enzyme quantity, rather than specific substrate preference, altered. occurs commonly with frequency 25-64% across populations analyzed. *55M common, occurring 5-40% individuals depending upon ethnic group studied. These data were incorporated into Monte Carlo simulations both alleles simultaneously modeled Caucasian, African American, Japanese populations. resulting distributions bimodal for approximately fourfold differences between low- high-activity modal medians. Differences total median 1st percentile five- sixfold. When sarin metabolic simulated, unimodal. However, there an even greater degree interindividual (median difference >20-fold). results show combined effects allelic variants yielded distribution associated considerable This indicates need evaluate polymorphism-related display internal doses adverse responses. may best achieved via physiologically based pharmacokinetic (PBPK) models input distributions, such those generated this analysis, simulate range possible population.

参考文章(166)
Clement E. Furlong, Brenda Eskenazi, Asa Bradman, Rebecca J. Richter, Nina Holland, Alan Ho, PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity Pharmacogenetics and Genomics. ,vol. 16, pp. 183- 190 ,(2006) , 10.1097/01.FPC.0000189796.21770.D3
D. J. Ecobichon, D. S. Stephens, Perinatal development of human blood esterases Clinical Pharmacology & Therapeutics. ,vol. 14, pp. 41- 47 ,(1973) , 10.1002/CPT197314141
C E Furlong, D M Shih, W F Li, R J Richter, L G Costa, E Alleva, A J Lusis, Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1). Neurotoxicology. ,vol. 21, pp. 91- 100 ,(2000)
Xiao-ming He, Zhen-xin Zhang, Jun-wu Zhang, Yong-tao Zhou, Mou-ni Tang, Cheng-Bin Wu, HONG Zhen, None, Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population. Chinese Medical Journal. ,vol. 119, pp. 1204- 1209 ,(2006) , 10.1097/00029330-200607020-00013
C E Furlong, A G Motulsky, E R Giblett, J Anderson, S Hornung, R F Mueller, Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies. American Journal of Human Genetics. ,vol. 35, pp. 393- 408 ,(1983)
Boris Bryk, Liat BenMoyal-Segal, Erez Podoly, Oded Livnah, Arik Eisenkraft, Shai Luria, Amir Cohen, Yoav Yehezkelli, Ariel Hourvitz, Hermona Soreq, Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities. Journal of Neurochemistry. ,vol. 92, pp. 1216- 1227 ,(2005) , 10.1111/J.1471-4159.2004.02959.X
J. T Salonen, R. Malin, T.-P. Tuomainen, K. Nyyssonen, T. A Lakka, T. Lehtimaki, M. D Flather, Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. BMJ. ,vol. 319, pp. 487- 489 ,(1999) , 10.1136/BMJ.319.7208.487
Diana M. Shih, Lingjie Gu, Yu-Rong Xia, Mohamad Navab, Wan-Fen Li, Susan Hama, Lawrence W. Castellani, Clement E. Furlong, Lucio G. Costa, Alan M. Fogelman, Aldons J. Lusis, Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature. ,vol. 394, pp. 284- 287 ,(1998) , 10.1038/28406
A Smolen, N Hailat, B N La Du, K N Gan, H W Eckerson, Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. Drug Metabolism and Disposition. ,vol. 19, pp. 107- 112 ,(1991)
J A Vitarius, L G Sultatos, Kinetic mechanism of the detoxification of the organophosphate paraoxon by human serum A-esterase. Drug Metabolism and Disposition. ,vol. 22, pp. 472- 478 ,(1994)